Abasaglar® (formerly Abasria®)
ACTIVE PRINCIPLE:
Insulin glargine
INDICATION:
Diabetes Mellitus
DATE:
09/09/2014
STATUS:
Authorized
Biosimilar medicine authorized by the European Commission
ACTIVE PRINCIPLE:
Insulin glargine
INDICATION:
Diabetes Mellitus
DATE:
09/09/2014
STATUS:
Authorized
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.